A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Rituximab (Primary) ; Methylprednisolone; Prednisone
- Indications Microscopic polyangiitis; Wegener's granulomatosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 15 Jun 2017 Planned End Date changed from 1 Apr 2018 to 30 Jun 2021.
- 15 Jun 2017 Planned primary completion date changed from 1 Apr 2018 to 30 Jun 2021.
- 10 Jun 2017 Biomarkers information updated